Lack of association between aspirin triggered 15-hydroxyeicosatetraenoic acid release and mast cell/eosinophil activation in nasal polyps from aspirin-sensitive patients

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 7, 2011, Pages 507-513

  Lewandowska Polak, A ^a   Jedrzejczak Czechowicz, M ^a   Makowska, J S ^a   Jarzebska, M ^a   Jankowski, A ^a   Kowalski, M L ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

15 HETE; Aspirin sensitivity; Misoprostol; Nasal polyps

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ACETYLSALICYLIC ACID; CALCIUM IONOPHORE; EOSINOPHIL CATIONIC PROTEIN; LEUKOTRIENE C4; MISOPROSTOL; TRYPTASE;

ADULT; AGED; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MAST CELL; NOSE POLYP; RHINOSINUSITIS;

ADULT; AGED; AGED, 80 AND OVER; ARACHIDONATE 15-LIPOXYGENASE; ASPIRIN; CALCIUM IONOPHORES; DRUG HYPERSENSITIVITY; EOSINOPHILS; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; MALE; MAST CELLS; MIDDLE AGED; MISOPROSTOL; NASAL POLYPS;

EID: 83755225428     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Szczeklik A, Sanak M. The broken balance in aspirin hypersensitivity. Eur J harmacol. 2006;533:145-55.
2. Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006;118:773-86; quiz 787-8.
3. Picado C. Mechanisms of aspirin sensitivity. Curr Allergy Asthma Rep.2006;6:198-202.
4. Gaber F, Daham K, Higashi A, Higashi N, Gulich A, Delin I, James A, Skedinger M, Gyllfors P, Nord M, Dahlen SE, Kumlin M, Dahlen B. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirinintolerant asthma. Thorax. 2008;63:1076-82.
5. Pérez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal olyposis. J Allergy Clin Immunol. 2005;115:1189-96.
6. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotrienereceptor expression on nasal mucosal infl ammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 2002;347:1493-9.
7. Kowalski ML, Pawliczak R, Wozniak J, Siuda K, Poniatowska M, Iwaszkiewicz J, Kornatowski T, Kaliner MA. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med. 2000;161:391-8.
8. Pujols L, Mullol J, Alobid I, Roca-Ferrer J, Xaubet A, Picado C. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. J Allergy Clin Immunol. 2004;114:814-9.
9. Ying S, Meng Q, Scadding G, Parikh A, Corrigan CJ, Lee TH. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal infl ammatory cells. J Allergy Clin Immunol. 2006;117:312-8.
10. Kowalski ML, Ptasinska A, Bienkiewicz B, Pawliczak R, DuBuske L. Differential ffects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients. J Allergy Clin Immunol 2003;112:505-12.
11. Jedrzejczak-Czechowicz M, Lewandowska-Polak A, Bienkiewicz B, Kowalski ML. Involvement of 15-lipoxygenase and prostaglandin EP receptors in aspirin-triggered 15-hydroxyeicosatetraenoic acid generation in aspirin-sensitive asthmatics. Clin Exp Allergy. 2008;38:1108-16.
12. GINA Global Strategy for Asthma Management and Prevention, 2006 NHI Publications No 02-3659. GINA update 2008. http://www.ginasthma.org.
13. Lebel B, Crampette L, Vergnes C, Campbell AM, Bousquet J. Inhibition of mediator release from dispersed nasal polyp cells by cyclosporin A. Int Arch Allergy Immunol. 1998;116:284-7.
14. Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Rubin P, Cohn J, White MV, Igarashi Y, Kaliner MA, Drazen JM, Israel E. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 1994;94:1046-56.
15. Kowalski ML, Sliwinska-Kowalska M, Igarashi Y, White MV, Wojciechowska B, Brayton P, Kaulbach H, Rozniecki J, Kaliner MA. Nasal secretions in response to acetylsalicylic acid. J Allergy Clin Immunol. 1993;91:580-98.
16. Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M. Intranasal challenge with aspirin induces cell infl ux and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin Exp Allergy. 1996;26:807-14.
17. Mita H, Endoh S, Kudoh M, Kawagishi Y, Kobayashi M, Taniguchi M, Akiyama K. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. Allergy. 2001;56:1061-7.
18. Kupczyk M, Antczak A, Kuprys-Lipinska I, Kuna P. Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysineaspirin nasal challenge in vivo model. Allergy. 2009;64:1746-52.
19. Kowalski ML, Ptasinska A, Jedrzejczak M, Bienkiewicz B, Cieslak M, Grzegorczyk J, Pawliczak R, DuBuske L. Aspirintriggered 15-HETE generation in peripheral blood leukocytes is a specifi c and sensitive Aspirin-Sensitive Patients Identifi cation Test (ASPITest). Allergy. 2005;60:1139-45.
20. Szczeklik A, Mastalerz L, Nizankowska E, Cmiel A. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am J Respir Crit Care Med. 1996;153:567-71.
21. Szmidt M, Wasiak W. The infl uence of misoprostol (synthetic analogue of prostaglandin E1) on aspirin-induced bronchoconstriction in aspirin-sensitive asthma. J Investig Allergol Clin Immunol. 1996;6:121-5.
22. Wang XS, Wu AY, Leung PS, Lau HY. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease. Allergy. 2007;62:620-7.
23. Kowalski ML, Lewandowska A, Wozniak J, Makowska J, Jankowski A, DuBuske L. Inhibition of nasal polyp mast cell and eosinophil activation by desloratadine. Allergy. 2005;60:80-5.
24. Perez-Novo CA, Kowalski ML, Kuna P, Ptasinska A, Holtappels G, van Cauwe nberge P, Gevaert P, Johannson S, Bachert C. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship.Int Arch Allergy Immunol. 2004;133:255-60.
25. Park HS, Jung KS, Shute J, Roberts K, Holgate ST, Djukanovic R. Allergen-induced release of GM-CSF and IL-8 in vitro by nasal polyp tissue from atopic subjects prolongs eosinophil survival. Eur Respir J. 1997;10:1476-82.
26. Feltenmark S, Gautam N, Brunnstrom A, Griffi ths W, Backman L, Edenius C, Lindbom L, Bjorkholm M, Claesson HE. Eoxins are proinfl ammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells. Proc Natl Acad Sci U S A. 2008;105:680-5.
27. Zhao J, Maskrey B, Balzar S, Chibana K, Mustovich A, Hu H, Trudeau JB, O'Donnell V, Wenzel SE. Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells. Am J Respir Crit Care Med. 2009;179:782-90.
28. Chu HW, Balzar S, Westcott JY, Trudeau JB, Sun Y, Conrad DJ, Wenzel SE. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy. 2002;32:1558-65.
29. Liu C, Xu D, Liu L, Schain F, Brunnstrom A, Bjorkholm M, Claesson HE, Sjoberg J. 15-Lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2009;297:L196-203.